A review of allergoid immunotherapy: is cat allergy a suitable target?. (March 2016)

• Record Type: Journal Article
• Authors: Nguyen, Nhung T; Raskopf, Esther; Shah-Hosseini, Kija; Zadoyan, Gregor; Mösges, Ralph
• Is Part Of: Immunotherapy. Volume 8:Number 3(2016:Mar.)
• Page Start: 331
• Page End: 349
• Publication Date: 2016-03
• Subjects: allergoid -- asthma -- cat allergy -- cat sensitization -- rhinitis -- SLIT -- specific immunotherapy; Immunotherapy -- Periodicals; 615.37
• DOI: 10.2217/imt.15.121
• Languages: English
• ISSNs: 1750-743X

Abstract

To modify the course of allergy, different types of specific allergen immunotherapy have been developed such as sublingual immunotherapy and subcutaneous immunotherapy with native allergens or subcutaneous immunotherapy with polymerized allergoids. However, the optimal specific immunotherapy, especially for cat allergy, remains undetermined. Few studies investigating immunotherapy in cat allergy have been published, and the risk of serious adverse reactions and systemic reactions has often been an important issue. Monomeric allergoids have lower allergenic potential while their immunogenicity remains constant, resulting in excellent safety with notable efficacy. Specific immunotherapy with monomeric allergoids could, therefore, be of high value, especially in cat allergy as well as other types of allergy, and bring relief to a great community of patients.